Clinical Trial Update: Cellular Immunotherapy for Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on cellular immunotherapy for septic shock, sponsored by the Ottawa Hospital Research Institute. The conditions include septic sho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Septic Shock, Sepsis | Phase 2 | Status: UNKNOWN